Industry Voices and Cannabis News | Page 28 of 142 | Cannabiz

Meet the appointed members of the scheduling committee who could shape THC’s regulatory future

by Adam Sheldon and Steve Jones March 18, 2026March 19, 2026

A panel of medical and scientific experts advising the federal government – including Australian Medical Association […]

Cash shortage offers only ‘limited window’ to sell Helius, administrator tells creditors

by Steve Jones March 18, 2026March 18, 2026

Australian exports to Germany triple as imports top 200 tonnes

by Adam Sheldon March 18, 2026March 18, 2026

Arjan Roskam UIC 2026

High THC ‘doesn’t mean a better therapeutic effect’, genetic expert tells prescribers

by Adam Sheldon March 17, 2026March 18, 2026

News in brief: Vitura signs MedReleaf deal; Neurotech initiates first site for Phase 3 autism trial

by Adam Sheldon March 17, 2026June 8, 2026

Rich Newman UIC 2026

‘Lawful practice’ not enough to avoid regulatory action, warns former AHPRA advisor

by Adam Sheldon March 17, 2026March 17, 2026

Former Cannim research lead takes senior role at Medigrowth

by Steve Jones March 16, 2026March 19, 2026

Cann Group secures $750k funding via convertible note

by Adam Sheldon March 16, 2026June 8, 2026

Head of Beacon Medical set to join Pharmacrop as commercial GM

by Steve Jones March 12, 2026March 12, 2026

Rec-style branding risks undermining the industry, warns Bioxyne CEO

by Adam Sheldon March 12, 2026March 12, 2026